Recently, the 11th Southwest Shandong Vascular Surgery Forum was successfully held in Qufu, Shandong! Kossel Medtech actively participated in the meeting. At the meeting, the team of Director Wang Xu of the Department of Vascular Surgery of Jining First People’s Hospital reviewed the first implantation of Kossel Medtech’s Octoparms® Vena Cava Filter after its launch, and started the post-collection clinical trial recently. The “first shot” of the application opened a new chapter in the application of domestic umbrella filters!

Kossel Medtech was a platform company with all-round production and research and development capabilities of vascular interventional devices, and is committed to providing clinical system solutions, with nearly 10,000 square meters of R&D and production bases, professional R&D and testing laboratories, systematic independent innovation R&D capabilities and leading manufacturing capabilities and nearly a hundred knowledge property. #PTA balloon catheter #Kossel Medtech# Vena Cava Filter